文献速递炎症性肠病

高强度托法替布诱导治疗4例急性重度溃疡性结肠炎的疗效

Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-11-17

本文报告了4例因急性重度溃疡性结肠炎(ASUC)住院、预测内科治疗可能失败的患者,首次使用超说明书高强度托法替布进行诱导治疗。托法替布是一种快速起效的口服小分子Janus激酶抑制剂,近期获美国食品药品监督管理局批准用于溃疡性结肠炎治疗。

要点

  • 4例ASUC住院患者预测内科治疗失败,接受超说明书高强度托法替布诱导治疗。
  • 托法替布为快速起效的口服小分子Janus激酶抑制剂,已获FDA批准治疗溃疡性结肠炎。
  • ASUC标准治疗为静脉糖皮质激素快速诱导,多达30%患者单用激素无应答。

核心结论

  • 本文首次报告了4例预测内科治疗失败的ASUC住院患者使用超说明书高强度托法替布诱导治疗。

研究设计与样本

  • 本文为病例报告,描述4例因ASUC住院且预测内科治疗失败的患者接受超说明书高强度托法替布诱导治疗。

主要发现

  • 多达25%的溃疡性结肠炎患者因急性重度溃疡性结肠炎(ASUC)发作住院。
  • ASUC住院患者的标准治疗依赖静脉糖皮质激素快速诱导,多达30%的患者单用糖皮质激素无应答。
  • 英夫利西单抗或环孢素挽救治疗可将90天结肠切除率降至20%。
  • 近年来因ASUC入院患者中已有越来越多的人英夫利西单抗治疗失败,凸显对这些患者额外治疗选择的需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As many as 25% of patients diagnosed with ulcerative colitis are hospitalized with an episode of acute severe ulcerative colitis (ASUC).1 The standard of care for patients hospitalized with ASUC relies on rapid induction with intravenous (IV) corticosteroids. Up to 30% of patients do not respond to corticosteroids alone.2 Rescue therapy with infliximab or cyclosporine has been shown to reduce rates of colectomy to 20% by 90 days.3,4 This still represents a significant rate of treatment failure, which leads to an unplanned and irreversible surgery. In recent years, increasing numbers of patients admitted with ASUC have already failed infliximab therapy, highlighting the need for additional treatment options for these patients. Tofacitinib is a rapidly acting, oral, small-molecule Janus kinase inhibitor that was recently approved by the Food and Drug Administration for treatment of ulcerative colitis.5 We present the first reported use of off-label, high-intensity tofacitinib in 4 patients admitted to our institution with ASUC predicted to fail medical management.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Berinstein JA, Steiner CA, Regal RE, et al. Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2018. PMID: 30458248. doi:10.1016/j.cgh.2018.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。